Advanced 3D mammography (tomosynthesis) reveals breast cancers not easily identified in traditional 2D mammography.
“There are still 40,000 American women who will die from breast cancer this year; more than all OB/GYN cancers combined,” says Dr. Elliott, Founder of Montclair Breast Center.
Montclair, NJ (PRWEB) May 28, 2014
Dr. Nancy Elliott, Founder of Montclair Breast Center, Montclair, NJ commented; “Recent media attention to a deeply flawed study from the British Medical Journal (BMJ) is disappointing. The BMJ article, published on February 11, 2014, is based on the widely discredited Canadian National Breast Screening Study, which used a fundamentally corrupted allocation process for the two patient groups that were compared; it was also based on mammograms from the 1980’s that were of incredibly poor quality, even by the standards of 35 years ago. Longer follow-up in this case does not improve the results. Unfortunately, media coverage of this study has resulted in needless and potentially dangerous confusion of many women. It risks the lives of women by calling into question the great advantages of early detection in breast cancer that I have seen during my 25 years of practice at Montclair Breast Center.”
Before mammography screening began at a national level in the U.S. in the mid-1980’s, the death rate from breast cancer had been unchanged for 50 years. There are now 30% fewer deaths from breast cancer in the U.S. compared to the time period before mammography screening was widely available to American women.
Over the past 20 years Montclair Breast Center has maximized the effectiveness of screening mammography with a combination of improved technology (3D mammography), expertise (experienced Fellowship trained breast imagers) and our unique comprehensive patient care model (including physician review of mammogram results with patients). They have also increased the sensitivity of screening by taking breast density and individual risk factors into account for patients who might require second-level screening tests (i.e. breast ultrasound and breast MRI). As a result, the Montclair Breast Center patient outcomes for early detection of breast cancer far exceed the national average and demonstrate the efficacy of routine screening mammography.
Dr. Elliott recommends annual mammography starting at age 40 (and younger if at high risk) because breast cancer is the number one killer of women, in ages 40 to 55. “There are still 40,000 American women who will die from breast cancer this year; more than all OB/GYN cancers combined. Women typically visit an OB/GYN physician on a regular basis, but all the GYN cancers taken together; uterine, ovarian, cervical, etc., are just one third the incidence of breast cancer,” says Dr. Elliott.
Montclair Breast Center is recognized and designated as a Breast Imaging Center of Excellence by the American College of Radiology and was one of the first breast centers in New Jersey to provide breast tomosynthesis or 3D mammography. They were also one of the first breast centers to offer Breast Specific MRI and Gamma Imaging. They continue to provide innovative, state-of-the-art technology to their patients because they know that it is important to always remain one step ahead.
For more information about the early detection of breast cancer, visit: Montclair Breast Center.
About Montclair Breast Center:
Montclair Breast Center is a premier multidisciplinary breast center located at 37 N. Fullerton Avenue in Montclair, NJ, specializing in proactive breast healthcare, risk-reduction techniques and the early detection and treatment of breast cancer. Our nationally recognized, dedicated team of breast imagers and breast surgeons use the most sophisticated technologies housed in our own facility and are committed to providing the best possible rate of early detection. Visit http://www.montclairbreastcenter.com for specifics. In 1998, Montclair Breast Center became an out-of-network breast center to provide care solely dictated by the needs of our patients, uncompromised by the restrictions and limitations imposed by managed healthcare corporations.
